Scribe Therapeutics adopts amended and restated bylaws effective at IPO close - SCTX News | RalliesScribe Therapeutics adopts amended and restated bylaws effective at IPO close
S
SCTX• Amended and restated bylaws take effect at IPO close
- Scribe Therapeutics filed an amended and restated certificate of incorporation in Delaware on July 27, 2026.
- Amended and restated bylaws became effective at the closing of its initial public offering.
- Changes align with provisions described in the final IPO prospectus dated July 23, 2026.
